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Abstract
Biosensors that report endogenous protein activity in vivo can be based on environment-sensing 
fluorescent dyes. The dyes can be attached to reagents that bind selectively to a specific 
conformation of the targeted protein, such that binding leads to a fluorescence change. Dyes that 
are sufficiently bright for use at low, non-perturbing intracellular concentrations typically undergo 
changes in intensity rather than the shifts in excitation or emission maxima that would enable 
precise quantitation through ratiometric imaging. We report here mero199, an environment-
sensing dye that undergoes a 33-nm solvent-dependent shift in excitation. The dye was used to 
generate a ratiometric biosensor of Cdc42 (CRIB199) without the need for additional 
fluorophores. CRIB199 was used in the same cell with a FRET sensor of Rac1 activation to 
simultaneously observe Cdc42 and Rac1 activity in cellular protrusions, indicating that Rac1 but 
not Cdc42 activity was reduced during tail retraction, and specific protrusions had reduced Cdc42 
activity. A novel program (EdgeProps) used to correlate localized activation with cell edge 
dynamics indicated that Rac1 was specifically reduced during retraction.
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INTRODUCTION
Fluorescent biosensors elucidate the flow of information through signaling networks in 
living cells and animals.1 To minimize intracellular biosensor concentration, biosensors 
ideally are bright and fluoresce at wavelengths longer than cellular autofluorescence. 
Biosensors based on solvent-sensitive fluorescent dyes may be constructed by attaching the 
dye directly to the protein of interest, where fluorescence changes are associated with 
changes in conformation.2,3 Alternatively, solvent-sensitive dyes may be attached to ‘affinity 
reagents’ that bind selectively to a given state of endogenous target proteins, leading to 
fluorescence change.4–7 Biosensors based on solvent-sensitive dyes offer substantially 
enhanced sensitivity over the more common biosensors based on fluorescence resonance 
energy transfer (FRET), in that bright dyes can be directly excited. However, bright dyes are 
more likely to respond to environment changes with shifts in fluorescence intensity rather 
than shifts in excitation/emission maxima, as there is an inverse relationship between dye 
brightness and the extent of solvent-dependent wavelength shifts.8–10 Intensity changes are 
difficult to measure in cells because intensity is subject to multiple sources of artifacts (e.g. 
uneven illumination and variations in cell thickness). This has been overcome using 
ratiometric imaging (Figure 1a), in which a second, minimally-responsive fluorophore is 
attached to the biosensor. Ratiometric imaging is challenging because it requires site-specific 
attachment of two fluorophores without perturbing protein activity, and quantitation is 
complicated when the two fluorophores bleach at different rates. Importantly, two dyes use 
up more of the wavelength spectrum than would a single fluorophore, making it difficult to 
use multiple biosensors in the same cell. We describe here mero199, a bright, long 
wavelength dye that undergoes solvent-dependent changes in its excitation maxima, 
enabling ratio imaging with a single dye (Figure 1b).
Among environment-sensing small molecule fluorophores, merocyanine dyes are especially 
well suited for live cell imaging. They can be bright, can emit at wavelengths that minimally 
overlap with cellular autofluorescence, and can exhibit solvent-dependent changes in 
extinction coefficient, fluorescence quantum yield (QY) or excitation/emission maxima.11,12 
Merocyanine dyes incorporate electron donor and acceptor moieties linked by conjugation.13 
The photophysical properties of the dyes depend on the specific donor/acceptor combination 
and on the nature of the conjugation.8,9,14 Previous studies indicate that brightness is 
maximized when the ground state is comprised of equal contributions from zwitterionic and 
non-polar resonance forms (the so-called cyanine limit, Scheme 1a), while solvent 
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sensitivity is maximized when the zwitterionic or non-polar ground states 
predominate.10,15,16 Consistent with this model, our earlier studies showed that the 3,3-
dimethylindolenine donor heterocycle (Scheme 1b) leads to extraordinarily bright dyes when 
combined with several acceptors, but these dyes all show limited solvent-dependent changes 
in fluorescence.9 In contrast, we found that pyridine donors and quinoline donors (Scheme 
1c) could produce exceptionally large solvent-dependent shifts in fluorescence maxima, but 
these dyes were too dim for practical live cell imaging.9 Dyes with pyridine and quinoline 
donors likely favor the ground state zwitterionic resonance form rather than the cyanine 
limit, because the zwitterionic form increases the aromaticity of the donor heterocycle 
(unlike the indolenine donor). The quinoline and pyridine-containing dyes showed 
hypsochromic shifts with increasing solvent polarity,9 indicating that their ground state is 
more polar than their excited state.17 Dyes with the indolenine donor are brighter not only 
because they can approach the cyanine limit, but also because the indolenine imparts 
extended conjugation and its geminal dimethyl substitution reduces aggregation-induced 
fluorescence quenching. We sought to produce a dye that combined the brightness of the 
indolenine donor with the solvent response of the quinoline donor, leading to the design of 
mero199 (Scheme 1), a dye based on a fused pyrido-indolium donor heterocycle.8 Like the 
quinoline, aromaticity is enhanced when the dye is in the charged form, favoring solvent-
sensitivity, but the predominance of the charged resonance form is not as strong as in 
quinoline itself. This structure proved to be substantially brighter than the quinoline-
containing dyes, likely because of the conjugation provided by the indolenine’s 6-membered 
ring and reduced aggregation.
Photobleaching was an important consideration in the development of mero199, as our 
survey of donor/acceptor combinations had also shown an inverse relationship between 
solvent sensitivity and photostability.9 Photodegradation of merocyanine dyes proceeds 
through attack of singlet oxygen at the most nucleophilic α-carbon of the central 
polymethine chain, and the reactivity of this position is enhanced for dyes further from the 
cyanine limit.18 A barbituric acid acceptor produced the best compromise between solvent-
sensitivity, brightness and photostability (data not shown). Substitution with an electron 
withdrawing group at the nucleophilic position of the polymethine chain can significantly 
increase photostability, so we incorporated the cyano group in the mero199 structure.14,18 
Finally, a sulfonate group was included for water solubility and a cysteine-reactive 
iodoacetamide group was included for site-specific labeling of proteins or other affinity 
reagents.19
RESULTS AND DISCUSSION
Synthesis of mero199 began with condensation of the commercially available 2,3,3-
trimethylindolenine (1, Scheme 2) with N-hydroxymethyl-phthalimide, followed by 
preparation of the product as its perchlorate salt to give compound 2. Conjugate addition of 
methyl vinyl ketone to compound 2 was followed by heating of the open chain adduct in 
pyridine to give the fused pyridinium salt (3).20 To ensure protecting group compatibility 
with subsequent reaction conditions, the phthalimide group was removed and the resulting 
primary amine was re-protected with Boc, followed by base promoted addition of N,N-
dimethylformamide dimethyl acetal to give the enamine 4. Treatment of compound 4 with 
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hydroxylamine-O-sulfonic acid resulted in expulsion of dimethylamine to afford the nitrile-
substituted product21 that was subsequently reacted with a barbituric acid bearing a methyl 
enol ether to give the merocyanine intermediate 5.18 The Boc group was removed under 
mild neutral conditions using iodotrimethylsilane to give compound 6. The free amine of 
compound 6 was then reacted with 1,3-propanesultone, followed by treatment with 
iodoacetic anhydride to provide the desired iodoacetamide-substituted dye, mero199, in a 
total of 12 linear steps.
We characterized the effects of solvent polarity on the fluorescence properties of mero199 
using previously reported methods (Table 1, Figure 2).9 Increased solvent polarity led to 
hypsochromic shifts in both excitation and emission maxima, with a difference of 33 nm 
between the excitation maxima in water and butanol. Extinction coefficients in methanol and 
butanol were among the highest we have observed (2.1 × 105 M−1cm−1 and 1.9 × 105 
M−1cm−1, respectively), and the dye’s relative brightness (ε x QY) compared favorably with 
other merocyanines that have been used in dye-based biosensors.2,5,9 In water versus 
butanol, the dye showed a greater than 16-fold change in brightness. The photostability of 
mero199 was 5.8- fold greater than the reference dye fluorescein (Figure S1). Together, 
these studies demonstrated that mero199 possessed the desired combination of solvent-
sensitive fluorescence, brightness, water solubility, and photostability to be used in 
ratiometric live cell biosensor applications.
We next tested mero199 by using it to make an actual biosensor, based on our previous 
approach to visualize the nucleotide state of the small GTPase Cdc42 in live cells.4 Cdc42 is 
a member of the Rho family of GTPases, proteins that regulate diverse aspects of cell 
behavior including cytoskeletal dynamics and migration.22 The Cdc42/Rac interactive 
binding (CRIB) domain derived from the Wiskott-Aldrich syndrome protein (WASP) binds 
only to the “activated,” GTP-bound conformation of Cdc42.23 This domain was mutated to 
include a single cysteine at position 271, a residue known to be near a hydrophobic pocket 
generated upon binding of the CRIB domain to activated Cdc42.24 Previous studies showed 
that environment-sensing fluorophores at this position exhibited significant changes in 
fluorescence intensity when the labeled CRIB bound to activated Cdc42 in cells.4 
Previously-used dyes changed intensity but not excitation/emission maxima, so it had been 
necessary to attach a second, non-responsive fluorophore to the biosensor for ratio 
imaging.4,25 Our new biosensor, named CRIB199, was based on attachment of mero199 at 
the same position. It was assessed in vitro using the methods previously validated for the 
two fluorophore biosensor.9 CRIB199 showed a 12 nm shift in excitation maximum upon 
binding Cdc42, while the emission maximum remained at 618 nm (Figure S2). Fluorescence 
intensity increased nearly 4-fold upon Cdc42 binding. The dissociation constant (Kd) of the 
Cdc42-biosensor conjugate (219 ± 87 nM) was slightly higher than that of unlabeled CRIB 
binding to Cdc42 (77 ± 9 nM), as with the previously reported dye-based biosensor (Figure 
S3).26,4,9 Cdc42 binding induced a maximum decrease in emission at 577 nm, and 
maximum increase in emission at 605 nm (Figure S4), leading us to use these two 
wavelengths for ratio imaging.
To test the ability of CRIB199 to report Cdc42 activation in living cells, the biosensor was 
microinjected into mouse embryonic fibroblasts (MEFs). For ratio imaging, we obtained two 
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images at each time point, one excited with a 577/10 bandpass filter and the other with a 
605/15 nm filter, and using a 630/45 nm emission filter for both. Dividing the two images on 
a pixel by pixel basis as previously described27 yielded a map of ratio values across the cell 
(Figure 3). As described previously, biosensor concentrations were adjusted to report Cdc42 
activity while minimizing perturbation of normal Cdc42 signaling.5,27–29 Consistent with 
earlier studies, Cdc42 was locally activated in protrusions. A control biosensor with point 
mutations known to reduce the CRIB domain’s affinity for active Cdc42 (mutantCRIB199, 
H246D and H249D)4,30 reduced the level of Cdc42 activation seen in the cells (Figures 3 
and S5). These studies showed that a biosensor made with mero199 could quantify protein 
activity in living cells using ratiometric imaging without the need for attachment of a second 
fluorophore.
One important advantage of CRIB199 is that it uses substantially less of the wavelength 
spectrum than biosensors based on two fluorophores (e.g. for FRET). To quantify the 
relative kinetics and subcellular localizations of two complex protein activities, it is valuable 
to visualize two protein activities in the same cell. Simultaneous imaging can be simplified 
using biosensors based on mero199. To demonstrate this, we studied activation of Cdc42 
and Rac1 by combining CRIB199 with a FRET-based biosensor of Rac129 that uses 
wavelengths typical of the majority of genetically encoded FRET sensors (Figure 4, Web 
Enhanced Object 1). Rac1 and Cdc42 both regulate the dynamics of the cell edge during 
motility and both are active in protrusions.29 It has been shown that there are a variety of 
protrusions with different functions and differences in signaling,31 but in many cases these 
cannot be distinguished based simply on inspection of protrusion morphology. We reasoned 
that Cdc42 and Rac1 would not be activated similarly in all protrusions, enabling us to 
distinguish live cell protrusions of different function and/or driven by different mechanisms.
We were concerned that loading two biosensors in the same cell would affect normal 
morphodynamics. Quantifying protrusion velocity distributions and the extent of protrusion 
versus retraction indicated that the two biosensors could be used simultaneously with little 
perturbation of protrusion behavior (Figure S6). Variations in the relative activity of Cdc42 
and Rac1 among different protrusions was apparent even from visual inspection of ratio 
images. The retracting tails of moving cells showed more Cdc42 than Rac1 activity, while 
protrusions at the leading edge varied -- both Cdc42 and Rac1 were elevated in some 
protrusions while only Rac1 predominated in others (Figure 4a). This demonstrated the 
ability of simultaneous imaging to distinguish protrusions on the basis of internal signaling 
activity. The differences between leading edge protrusions suggested that they had different 
functions or behaviors despite similar morphology. Activation of Cdc42 in only some 
protrusions is consistent with its role in controlling the direction of cell movement.22
The absence of Rac1 in retracting cell tails suggested that retraction was associated with 
reduced Rac1 activity. This is consistent with Rac1’s known role in polymerizing dendritic 
actin to drive protrusion. To probe this, we developed a software tool (EdgeProps – see 
Supporting Information) that correlated biosensor activity with the velocity of neighboring 
regions of the cell edge. For a series of equally spaced points covering the entire edge, the 
program determined activation level and velocity at each point over time. This analysis 
revealed that both Cdc42 and Rac1 activity increased with velocity during protrusion, but 
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that Rac1 activity was reduced relative to Cdc42 during retraction (Figure 4b). Cdc42 has 
been shown to be required for actomyosin contractility at the cell edge, and to be involved in 
stimulated cell repulsion events, in accordance with these observations.32,33
CONCLUSIONS
In summary, we have developed mero199, a novel dye that enables construction of live cell 
biosensors using a single dye, yet is capable of ratio imaging. Building a biosensor by using 
only a single fluorophore facilitates combination with other molecular imaging tools; the 
excitation and emission wavelengths of mero199 are compatible with pairs of fluorescent 
proteins used in FRET biosensors, and mero199 excitation does not overlap that of 
photoresponsive proteins used for optogenetics. GTPases, and many other signaling proteins, 
show heterogenous and complex responses in living cells. Simultaneous imaging will 
facilitate the identification of dynamic cellular structures on the basis of multiple signaling 
activities, and can precisely define the relative localizations and kinetics of activation for two 
proteins. Dye-based biosensors have seen less use than biosensors based on FRET, likely 
because they are more cumbersome to introduce into cells. However, they have important 
advantages in brightness, sensitivity, and their ability to probe different aspects of the 
intracellular environment. We hope that dye-based biosensors will soon be more accessible 
given recent efforts to covalently derivatize proteins with great specificity in living 
cells.34–36
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Figure 1. 
Ratiometric imaging with a dual versus single fluorophore biosensor. (a) The affinity reagent 
(AR) binds to the protein of interest (POI) only when the POI is in the active state. The 
changing intensity of the dye (red) relative to the fixed intensity of the fluorescent protein 
(FP) reflects POI binding. (b) POI activation is reflected simply in the ratio of emission at 
two different mero199 excitation wavelengths.
MacNevin et al. Page 8
J Am Chem Soc. Author manuscript; available in PMC 2017 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Excitation (a) and emission (b) fluorescence spectra of mero199 in selected solvents.
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Figure 3. 
Migrating MEF cells microinjected with CRIB199, the biosensor based on mero199 
conjugated to the CRIB domain, show Cdc42 activity in protrusions at the leading edge. 
Cells containing a mutant biosensor with reduced affinity for Cdc42 (mutantCRIB199) 
showed substantially less Cdc42 activation (images are scaled identically to show this). The 
pseudocolor scale shows the increase in ratio relative to the lowest 5% of ratio values in the 
cell (see Figure S5). These low values were similar for the two biosensors. The white arrow 
indicates the direction of movement.
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Figure 4. 
Migrating MEF cells containing both a FRET-based Rac1 biosensor and CRIB199, a Cdc42 
biosensor based on mero199 conjugated to the CRIB domain of WASP. (a) Ratiometric 
images of Cdc42 and Rac1 activity (dotted box = cell tail undergoing retraction, solid box = 
protrusion along the leading edge). Note that the leading edge protrusion in the box shows 
high Cdc42 and Rac1 activity, while the protrusion at upper right has similar Rac1 activity 
but reduced Cdc42 activity. (b) Plot of activation vs. cell edge velocity for Rac1 versus 
Cdc42 (n = 3 cells). The readouts of the two biosensors were normalized such that when 
edge velocity was zero, both biosensors were set to zero, and the biosensors’ maximum 
values (which in both cases occurred for protrusions at maximum velocity) were set equal to 
1.
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Scheme 1. 
Rational design of ratiometric dye mero199. A fused pyrido-indolium donor heterocycle 
was included for enhanced solvatochromic properties.
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Scheme 2. 
Synthesis of mero199. Reagents and conditions: a) H2SO4, N-hydroxymethyl-phthalimide, 
0 °C – RT, 50%; b) HClO4, EtOH, reflux, 90%; c) methyl vinyl ketone, 100 °C, 62%; d) 
pyridine, reflux, 28%; e) NH2NH2.H2O 3:2 CH2Cl2/MeOH, 98%; f) Boc2O, Et3N, 3:1 
CH2Cl2/ACN; g) (CH3O)2CHN(CH3)2, cat. DBU, DMF, 100 °C, 68% from 3; h) NH2SO3H, 
1:1 MeOH/H2O; i) 5-(3)-methoxy-allylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione, 
NaOAc, 1:1 CH2Cl2/MeOH, reflux, 29% from 4; j) (CH3)3SiI, ACN, 87%; k) 1,3-propane 
sultone, NMP, NaOAc,; l) (ICH2CO)2O, NMP, 30% from 6.
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